Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Attendo

125.70 SEK0.00 %11.9. klo 16.02
Less than 1K followers

ATT

NASDAQ Stockholm

Health Care Providers

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
0.00 %
+17.70 %
+7.90 %
+21.57 %
+53.48 %
+83.50 %
+323.23 %
+211.14 %
+79.57 %

Attendo operates in the healthcare industry and focuses on the operation of residential and home care services for the elderly and people with disabilities. The company's services are aimed at private individuals and public institutions. The operations are primarily concentrated in the Nordic region, with a main presence in Sweden, Finland and Norway. Attendo was founded in 1985 and is headquartered in Danderyd, Sweden.

Read more
Market cap
18.2B SEK
Turnover
9.15M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
6.11.
2026

Interim report Q3'26

9.11.
2026

Half year dividend

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release08.09.2026 klo 09.00

Repurchases of shares during week 36, 2026

Attendo
Regulatory press release07.09.2026 klo 09.00

Attendo appoints Virpi Holmqvist as new President and CEO

Attendo
Press release03.09.2026 klo 14.30

Press invitation to Attendolunken 2026

Attendo

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release01.09.2026 klo 09.00

Repurchases of shares during week 35, 2026

Attendo
Press release27.08.2026 klo 10.30

Construction begins on Attendo’s new nursing home in Upplands-Bro, Sweden

Attendo
Press release26.08.2026 klo 10.30

Construction begins on Attendo’s new nursing home in Mölndal, Sweden

Attendo
Attendo, Audiocast, Q2'26
Webcast20.08.2026 klo 11.00

Attendo, Audiocast, Q2'26

Attendo
Press release20.08.2026 klo 09.15

Attendo signs new long-term financing agreement linked to social sustainability

Attendo
Regulatory press release20.08.2026 klo 09.10

Attendo to buy back shares for a maximum amount of SEK 250 million

Attendo
Regulatory press release20.08.2026 klo 09.05

Repurchases of shares during week 34, 2026

Attendo
Regulatory press release20.08.2026 klo 09.00

Attendo’s second quarter report 2026: Strong performance in both business areas and accelerated investment pace

Attendo
Press release19.08.2026 klo 10.30

Unika launches Move – a new concept in daily activities

Attendo
Regulatory press release18.08.2026 klo 09.00

Repurchases of shares during week 33, 2026

Attendo
Press release13.08.2026 klo 09.30

Invitation to the presentation of Attendo's report for the second quarter of 2026

Attendo
Regulatory press release11.08.2026 klo 09.00

Repurchases of shares during week 32, 2026

Attendo
Regulatory press release04.08.2026 klo 09.00

Repurchases of shares during week 31, 2026

Attendo
Regulatory press release03.08.2026 klo 08.45

Attendo has received competition clearance for the acquisition of A-klinikka Oy

Attendo
Regulatory press release28.07.2026 klo 09.00

Repurchases of shares during week 30, 2026

Attendo
Regulatory press release21.07.2026 klo 09.00

Repurchases of shares during week 29, 2026

Attendo
Regulatory press release14.07.2026 klo 09.00

Repurchases of shares during week 28, 2026

Attendo